The Level of Cytokeratin 18 in Patients with HIV and Viral Hepatitis C Co-Infection in Latvia

Koļesova, Oksana; Madelāne, Monta; Ekšteina, Ilze; Koļesovs, Aleksandrs; Krūmiņa, Angelika; Vīksna, Ludmila

doi:10.2478/prolas-2020-0015

Abstract

Cytokeratin 18 (CK18) is a specific marker of hepatocellular apoptosis, which is a useful noninvasive indicator of liver fibrosis in the HIV/HCV group. However, data on the CK18 level in serum are limited for this group. This study demonstrated CK18 levels in serum in HIV/HCV co-infected and HIV mono-infected patients; investigated the association of CK18 levels with other non-invasive markers of liver fibrosis; and presents CK18 dynamics in a four-month-long period. The sample included 273 patients with HIV infection (128 of them were with HIV/HCV co-infection) aged from 23 to 65 (35% females). Levels of hyaluronic acid, CK18, ALT, and AST were determined in serum, and the FIB4 index was calculated. All markers had higher levels in the HIV/HCV group than in the HIV mono-infection group. The HIV/HCV group demonstrated coherent correlations among the markers and their associations with the level of CK18 than the HIV mono-infection group. During the four-month-long period, the CK18 level in serum showed no significant changes.

References

Aida, Y., Abe, H., Tomita, Y., Nagano, T., Seki, N., Sugita, T., Itagaki, M., Ishiguro, H., Sutoh, S., Aizawa, Y. (2014). Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease. Int. J. Clin. Exp. Med., 7 (11), 4191–4198.
Search in Google Scholar Back to article
Apostolova, N., Gomez-Sucerquia, L. J., Gortat, A., Blas-Garcia, A., Esplugues, J. V. (2011). Compromising mitochondrial function with the antiretroviral drug efavirenz induces cell survival-promoting autophagy. Hepatology, 54 (3), 1009–1019.10.1002/hep.2445921626526
Search in Google Scholar Back to article
Benmassaoud, A., Ghali, P., Cox, J., Wong, P., Szabo, J., Deschenes, M., Osikowicz, M., Lebouche, B., Klein, M. B., Sebastiani, G. (2018). Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection. PloS ONE, 13 (1), e0191985.10.1371/journal.pone.0191985579026029381754
Search in Google Scholar Back to article
Blackard, J. T., Sherman, K. E. (2008). HCV/HIV co-infection: Time to re-evaluate the role of HIV in the liver? J. Viral Hepat., 15, 323–330.10.1111/j.1365-2893.2008.00970.x352683218208497
Search in Google Scholar Back to article
Canbay, A., Friedman, S., Gores, G. J. (2004). Apoptosis: The nexus of liver injury and fibrosis. Hepatology, 39 (2), 273–278.10.1002/hep.2005114767974
Search in Google Scholar Back to article
Chew, K. W., Bhattacharya, D. (2016). Virologic and immunologic aspects of HIV-HCV co-infection. AIDS, 30 (16), 2395–2404.10.1097/QAD.0000000000001203603938627427873
Search in Google Scholar Back to article
Feldstein, A. E., Wieckowska,A., Lopez, A. R., Liu, Y.-C., Zein, N. N., McCullough, A. J. (2009). Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study. Hepathology, 50, 1072–1078.10.1002/hep.23050275751119585618
Search in Google Scholar Back to article
Friedman, S. L. (2010). Evolving challenges in hepatic fibrosis. Nat. Rev. Gastroenterol. Hepatol., 7, 425–436.10.1038/nrgastro.2010.9720585339
Search in Google Scholar Back to article
Ganesan, M., Dagur, R. S., Makarov, E., Poluektova, L. I., Kadambi, S., Osna, N. A. (2018). Matrix stiffness regulate apoptotic cell death in HIV-HCV co-infected hepatocytes: Importance for liver fibrosis progression. Biochem. Biophys. Res. Commun., 500, 717–722.10.1016/j.bbrc.2018.04.142686304929679566
Search in Google Scholar Back to article
Guicciardi, M. E., Gores, G. J. (2005). Apoptosis: A mechanism of acute and chronic liver injury. Gut, 54, 1024–1033.10.1136/gut.2004.053850177460115951554
Search in Google Scholar Back to article
Hong, F., Tuyama, A., Lee, T. F., Loke, J., Agarwal, R., Cheng, X., Garg, A., Fiel, M. I., Schwartz, M., Walewski, J., Branch, A., Schecter, A. D., Bansa, M. B. (2009). Hepatic stellate cells express functional CXCR4: Role in stromal cell-derived factor-1alphamediated stellate cell activation. Hepatology, 49, 2055–2067.10.1002/hep.22890289354719434726
Search in Google Scholar Back to article
Hong, F., Saiman, Y., Si, C., Mosoian, A., Bansal, M. B. (2012). X4 Human iImmunodeficiency virus Type 1 gp120 promotes human hepatic stellate cell activation and collagen I expression through interactions with CXCR4. PLoS One, 7, e33659.10.1371/journal.pone.0033659
Search in Google Scholar Back to article
Kaspar, M. B., Sterling, R. K. (2017). Mechanisms of liver disease in patients infected with HIV. BMJ Open Gastro., 4, e000166.10.1136/bmjgast-2017-000166566326329119002
Search in Google Scholar Back to article
Kim, H. N., Nance, R., Rompaey, S. V., Delaney, J. C., Crane, H. M., Cachay, E. R., Geng, E., Boswell, S. L., Rodriguez, B., Eron, J., Saag, M., Moore, R. D., Kitahata, M. M. (2016). Poorly controlled HIV infection: An independent risk factor for liver fibrosis. J. Acquir. Immune Defic. Syndr., 72 (4), 437–443.10.1097/QAI.0000000000000992492518926990826
Search in Google Scholar Back to article
Kliemann, D. A., Wolff, F. H., Tovo, C. V., Alencastro, P. R., Ikeda, M. L. R., Brandćo, A. B. M., Barcellos, N., Fuchs, S. C. (2016). Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients. Ann. Hepatol., 15 (1), 27–32.10.5604/16652681.118419726626637
Search in Google Scholar Back to article
Chu, P. G., Weiss, L. M. (2002). Keratin expression in human tissues and neoplasms. Histopathology, 40, 403–439.10.1046/j.1365-2559.2002.01387.x12010363
Search in Google Scholar Back to article
Kobayashi, N., Kumada, T., Toyoda, H., Tada, T., Ito, T., Kage, M., Okanoue, T., Kudo, M. (2017). Ability of cytokeratin-18 fragments and FIB4 index to diagnose overall and mild fibrosis nonalcoholic steatohepatitis in Japanese nonalcoholic fatty liver disease patients. Digestive Dis., 35 (6), 521–530.10.1159/00048014229040984
Search in Google Scholar Back to article
Larrousse, M., Laguno, M., Segarra, M., De Lazzari, E., Martínez, E., Luis Blanco, J. L., León, A., Deulofeu, R., Miquel, R., Milinkovic, A., Lonca, M., Miró, J. M., Biglia, A., Murillas, J., Gatell, J. M., Mallolas, J. (2007). Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients. J. Acquir. Immune Defic. Syndr., 46, 304–311.10.1097/QAI.0b013e318152050218172937
Search in Google Scholar Back to article
de Lédinghen, V., Barreiro, P., Foucher, J., Labarga, P., Castéra, L., Vispo, M. E., Bernard, P.-H., Martin-Carbonero, L., Neau, D., García-Gascó, P., Merrouche, W., Soriano, V. (2008). Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. J. Viral Hepat., 15, 427–433.10.1111/j.1365-2893.2007.00962.x18221303
Search in Google Scholar Back to article
Maagaard, A., Kvale, D., Scand, J. (2009). Long term adverse effects related to nucleoside reverse transcriptase inhibitors: Clinical impact of mitochondrial toxicity. Infect Dis, 41 (11–12), 808–817.10.3109/00365540903186181
Search in Google Scholar Back to article
Macías, J., Japón, M. A., Sáez, C., Palacios, R. B., Mira, J. A., García-García, J. A., Merchante, N., Vergara, S., Lozano, F., Gómez-Mateos, J., Pineda, J. A. (2005). Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus co-infection. J. Inf. Dis., 192, 1566–1576.10.1086/49173616206071
Search in Google Scholar Back to article
Madelāne, M., Krūmiņa, A., Sīmanis, R., Šķenders, Ģ., Ivanovs, A., Stūre, G., Vīksna, L. (2019). Difference in markers of microbial translocation and cell apoptosis in HIV monoinfected and HIV/HCV coinfected patients. Proc. Latvian Acad. Sci., Section B, 73 (4), 304–311.10.2478/prolas-2019-0048
Search in Google Scholar Back to article
Marchetti, G., Tincati, C., Silvestri, G. (2013). Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin. Microbiol. Rev., 26, 2–18.10.1128/CMR.00050-12355366823297256
Search in Google Scholar Back to article
Mohsen, A. H., Easterbrook, P. J., Taylor, C., Portmann, B., Kulasegaram, R., Murad, S., Wiselka, M., Norris, S. (2003). Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut, 52, 1035–1040.10.1136/gut.52.7.1035
Search in Google Scholar Back to article
Neuman, M. G., Cohen, L. B., Nanaua R. M. (2016). Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin. Biochem., 49, 302–315.10.1016/j.clinbiochem.2015.07.019
Search in Google Scholar Back to article
Noguchi, K., Gel, Y. R., Brunner, E., Konietschke, F. (2012). nparLD: An R software package for the nonparametric analysis of longitudinal data in factorial experiments. J. Statist. Software, 50 (12), 1–23.10.18637/jss.v050.i12
Search in Google Scholar Back to article
Nunes, D., Fleming, C., Offner, G., Craven, D., Fix, O., Heeren, T., Koziel, M. J., Graham, C., Tumilty, S., Skolnik, P., Stuver, S., Horsburgh Jr, C. R., Cotton, D. (2010). Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Amer. J. Gastroenterol., 105, 1346–1353.10.1038/ajg.2009.746
Search in Google Scholar Back to article
Parfieniuk-Kowerda, A., Lapinski, T. W., Rogalska-Plonska, M., Swiderska, M., Panasiuk, A., Jaroszewicz, J., Flisiak, R. (2014). Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C. Liver Int, 34, 544–550.10.1111/liv.12297
Search in Google Scholar Back to article
Platt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., Yanny, Razavi, H., Vickerman, P. (2016). Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis. Lancet Infect. Dis., 16, 797–808.10.1016/S1473-3099(15)00485-5
Search in Google Scholar Back to article
Rockstroh, J. K., Peters, L., Grint, D., Soriano, V., Reiss, P., Monforte, Ad., Beniowski, M., Losso, M. H., Kirk, O., Kupfer, B., Mocroft, A., for EuroSIDA in EuroCoord. (2013). Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV? J. Hepatol., 59 (2), 213–220.10.1016/j.jhep.2013.04.00523583272
Search in Google Scholar Back to article
Rohrbach, J., Stickel, F., Schmid, P., Thormann, W., Kovali, H., Scherrer, A., Günthard, H. F., Vuichard, D., Cavassini, M., Ambrosioni, J., Bernasconi, E., Furrer, H., Rauch, A. and the Swiss HIV Cohort Study. (2013). Changes of biomarkers of liver disease during successful combination antiretroviral theraly in HIV/HCV-coinfected individuals. Antiviral Ther.,19, 149–159.10.3851/IMP268624036684
Search in Google Scholar Back to article
Scherzer, R., Heymsfield, S. B., Rimlanda, D., Rimlanda, D., Powdwrly, W. G., Tien, P. C., Bacchetti, P., Shlipak, M. G., Grunfeld, C. (2017). Association of serum albumin and AST with 5-year all-cause mortality in HIV/HCV coinfection and HIV monoinfection. AIDS, 31 (1), 71–79.10.1097/QAD.0000000000001278512777527677166
Search in Google Scholar Back to article
Schmid, P., Bregenzer, A., Huber, M., Rauch, A., Jochum, W., Müllhaupt, B., Vernazza, P., Opravil, M., Weber, R., Swiss HIV Cohort Study. (2015). Progression of liver fibrosis in HIV/HCV co-infection: A comparison between non-invasive assessment methods and liver biopsy. PLoS ONE, 10 (9), e0138838.10.1371/journal.pone.0138838458785926418061
Search in Google Scholar Back to article
Selvaraj, S., Ghebremichael, M., Li, M., Foli, Y., Langs-Barlow, A., Ogbuagu, A., Barakat, L., Tubridy, E., Edifor, R., Lam, W., Cheng, Y.-C., Paintsil, E. (2014). Antiretroviral therapy-induced mitochondrial toxicity: Potential mechanisms beyond polymerase-ć inhibition. Clin. Pharmacol. Ther., 96 (1), 110–120.10.1038/clpt.2014.64406519524637942
Search in Google Scholar Back to article
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Cassia, M., Correa, M. C., Montaner, J., Sulkowski, M. S., Torriani, F. J., Dieterich, D. T., Thomas, D. L., Messinger, D., Nelson, M. for the APRICOT Clinical Investigators. (2006). Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV co-infection. Hepatol. Baltim. Md, 43, 1317–1325.10.1002/hep.2117816729309
Search in Google Scholar Back to article
Vīksna, L., Keišs, J., Sočņevs, A., Rozentāle, B., Pilmane, M., Sevastjanova N., Buiíe, I., Jēruma, A., Eglīte, J., Ābeltiņa K., Sondore, V. (2009). Novel laboratory tests in assessment of liver function and acute and chronic viral liver diseases. Proc. Latvian Acad. Sci., Section B, 63 (4/5), 228–233.10.2478/v10046-009-0035-4
Search in Google Scholar Back to article
Vīksna, L., Ekšteina, I., Madelāne, M., Zeltiņa, I., Krūmiņa, A., Koļesovs, A., Simanis, R. (2019). Markers of liver fibrosis and apoptosis in patients with HIV mono-infection and HIV/HCV co-infection. HIV AIDS Rev., 18 (1), 33–39.10.5114/hivar.2019.84198
Search in Google Scholar Back to article
Wilen, C. B., Tilton, J. C., Doms, R. W. (2012). HIV: Cell binding and entry. Cold Spring Harb. Perspect. Med., 2:a006866.10.1101/cshperspect.a006866
Search in Google Scholar Back to article

The Level of Cytokeratin 18 in Patients with HIV and Viral Hepatitis C Co-Infection in Latvia

Abstract

Paradigm

My account